15.89
price up icon1.21%   0.19
after-market After Hours: 15.89
loading
Keros Therapeutics Inc stock is traded at $15.89, with a volume of 489.98K. It is up +1.21% in the last 24 hours and up +1.47% over the past month. Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.
See More
Previous Close:
$15.70
Open:
$15.72
24h Volume:
489.98K
Relative Volume:
1.19
Market Cap:
$645.38M
Revenue:
-
Net Income/Loss:
$-168.05M
P/E Ratio:
-3.0975
EPS:
-5.13
Net Cash Flow:
$-146.15M
1W Performance:
+1.73%
1M Performance:
+1.47%
6M Performance:
+30.46%
1Y Performance:
-73.42%
1-Day Range:
Value
$15.64
$16.14
1-Week Range:
Value
$15.50
$16.44
52-Week Range:
Value
$9.12
$72.37

Keros Therapeutics Inc Stock (KROS) Company Profile

Name
Name
Keros Therapeutics Inc
Name
Phone
617-314-6297
Name
Address
1050 WALTHAM STREET, SUITE 302, LEXINGTON, MA
Name
Employee
148
Name
Twitter
Name
Next Earnings Date
2024-11-04
Name
Latest SEC Filings
Name
KROS's Discussions on Twitter

Compare KROS with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
KROS
Keros Therapeutics Inc
15.89 637.66M 0 -168.05M -146.15M -5.13
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
407.37 104.55B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
464.95 60.36B 2.46B -319.09M -52.09M -2.4669
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
557.73 59.84B 14.21B 4.46B 3.56B 39.69
Biotechnology icon
ARGX
Argen X Se Adr
799.56 49.07B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
ONC
Beone Medicines Ltd Adr
327.03 35.16B 4.56B -176.77M 225.30M -1.7177

Keros Therapeutics Inc Stock (KROS) Upgrades & Downgrades

Date Action Analyst Rating Change
Jun-10-25 Downgrade BofA Securities Buy → Neutral
Jan-21-25 Downgrade Cantor Fitzgerald Overweight → Neutral
Jan-17-25 Downgrade Wedbush Outperform → Neutral
Dec-16-24 Downgrade Guggenheim Buy → Neutral
Dec-16-24 Reiterated Oppenheimer Outperform
Dec-13-24 Reiterated H.C. Wainwright Buy
Dec-12-24 Downgrade BTIG Research Buy → Neutral
Dec-12-24 Downgrade TD Cowen Buy → Hold
Dec-12-24 Downgrade William Blair Outperform → Mkt Perform
Nov-05-24 Initiated Jefferies Buy
Oct-24-24 Initiated Cantor Fitzgerald Overweight
Oct-16-24 Initiated Scotiabank Sector Outperform
Sep-23-24 Initiated Guggenheim Buy
Jun-25-24 Initiated Oppenheimer Outperform
Feb-21-24 Initiated William Blair Outperform
Dec-08-23 Initiated Wells Fargo Overweight
Jul-31-23 Initiated Wedbush Outperform
Jul-26-23 Initiated BofA Securities Buy
Feb-14-23 Initiated Cowen Outperform
Oct-18-22 Initiated Truist Buy
Jul-26-22 Initiated BTIG Research Buy
Dec-08-20 Reiterated H.C. Wainwright Buy
May-04-20 Initiated H.C. Wainwright Buy
May-04-20 Initiated Jefferies Buy
May-04-20 Initiated Piper Sandler Overweight
May-04-20 Initiated SVB Leerink Outperform
View All

Keros Therapeutics Inc Stock (KROS) Latest News

pulisher
11:41 AM

Keros Therapeutics Inc. stock trendline breakdownTrade Analysis Summary & Reliable Price Breakout Alerts - newser.com

11:41 AM
pulisher
11:12 AM

Historical volatility pattern of Keros Therapeutics Inc. visualizedJobs Report & Verified Chart Pattern Signals - newser.com

11:12 AM
pulisher
11:04 AM

Can volume confirm reversal in Keros Therapeutics Inc.New Guidance & Community Trade Idea Sharing - newser.com

11:04 AM
pulisher
09:49 AM

Published on: 2025-10-13 08:49:09 - newser.com

09:49 AM
pulisher
09:36 AM

How to recover losses in Keros Therapeutics Inc. stockJuly 2025 Catalysts & Reliable Price Action Trade Plans - newser.com

09:36 AM
pulisher
09:33 AM

Will breakout in Keros Therapeutics Inc. lead to full recoveryInsider Selling & High Win Rate Trade Tips - newser.com

09:33 AM
pulisher
09:28 AM

Why Keros Therapeutics Inc. stock remains undervaluedEarnings Overview Summary & Weekly High Return Opportunities - newser.com

09:28 AM
pulisher
09:00 AM

Forecasting Keros Therapeutics Inc. price range with options dataTrade Performance Summary & Fast Exit and Entry Strategy Plans - newser.com

09:00 AM
pulisher
08:22 AM

Can trapped investors hope for a rebound in Keros Therapeutics Inc.2025 Volatility Report & Real-Time Market Trend Scan - newser.com

08:22 AM
pulisher
05:19 AM

What hedge fund activity signals for Keros Therapeutics Inc. stock2025 Support & Resistance & Consistent Profit Alerts - newser.com

05:19 AM
pulisher
04:04 AM

Earnings visualization tools for Keros Therapeutics Inc.Quarterly Trade Report & Smart Swing Trading Techniques - newser.com

04:04 AM
pulisher
Oct 12, 2025

What analysts say about Keros Therapeutics Inc stockPrice Support Zones & High Yield Trading Signals - earlytimes.in

Oct 12, 2025
pulisher
Oct 10, 2025

Keros Therapeutics Inc. stock daily chart insightsMarket Volume Summary & Long Hold Capital Preservation Tips - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Published on: 2025-10-10 05:54:47 - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Weiss Ratings Reaffirms "Sell (D)" Rating for Keros Therapeutics (NASDAQ:KROS) - MarketBeat

Oct 10, 2025
pulisher
Oct 10, 2025

Investors in Keros Therapeutics (NASDAQ:KROS) have unfortunately lost 72% over the last year - Yahoo Finance

Oct 10, 2025
pulisher
Oct 09, 2025

Can machine learning forecast Keros Therapeutics Inc. recoveryPortfolio Value Summary & Expert Verified Movement Alerts - newser.com

Oct 09, 2025
pulisher
Oct 07, 2025

Public Employees Retirement System of Ohio Purchases Shares of 26,103 Keros Therapeutics, Inc. $KROS - MarketBeat

Oct 07, 2025
pulisher
Oct 06, 2025

Can Keros Therapeutics Inc. recover in the next quarterMarket Performance Recap & Growth Oriented Trading Recommendations - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

Can Keros Therapeutics Inc. rally from current levelsGap Down & Weekly Market Pulse Alerts - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

Will Keros Therapeutics Inc. bounce back from current supportQuarterly Earnings Report & Long-Term Capital Growth Strategies - newser.com

Oct 06, 2025
pulisher
Oct 05, 2025

How to interpret RSI for Keros Therapeutics Inc. stockWeekly Stock Summary & Proven Capital Preservation Methods - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

Quantitative breakdown of Keros Therapeutics Inc. recent moveTake Profit & Risk Controlled Stock Pick Alerts - newser.com

Oct 05, 2025
pulisher
Oct 03, 2025

Is Keros Therapeutics Inc. stock poised for growthTrade Analysis Report & Growth Oriented Trade Recommendations - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

What momentum indicators show for Keros Therapeutics Inc. stockWeekly Risk Report & Verified Entry Point Signals - newser.com

Oct 03, 2025
pulisher
Oct 02, 2025

Keros Therapeutics Inc Stock Analysis and ForecastHigh Yield Income Stocks & Low Entry Cost Investment - earlytimes.in

Oct 02, 2025
pulisher
Sep 29, 2025

Is Peeti Securities Limited Positioned to Benefit From Geographic ExpansionSector Performance Review & Achieve Triple Digit Returns - earlytimes.in

Sep 29, 2025

Keros Therapeutics Inc Stock (KROS) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading

Keros Therapeutics Inc Stock (KROS) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
ADAR1 Capital Management, LLC
10% Owner
Apr 09 '25
Buy
10.13
934,258
9,464,512
4,392,737
Seehra Jasbir
CHIEF EXECUTIVE OFFICER
Apr 04 '25
Option Exercise
0.30
49,367
14,810
302,223
$84.73
price up icon 1.11%
$22.93
price up icon 7.40%
$32.68
price up icon 2.73%
$102.30
price up icon 0.24%
$163.94
price up icon 0.99%
biotechnology ONC
$327.03
price up icon 2.16%
Cap:     |  Volume (24h):